Results 1 to 10 of about 19,792 (277)

Assessing the adherence to and the therapeutic effectiveness of hypolipidemic agents in a population of patients in Brazil: a retrospective cohort study [PDF]

open access: greenPharmacy Practice, 2014
Objective: to evaluate the relation between patient adherence and therapeutic effectiveness of hypolipidemic agents in clinical practice. Methods: A retrospective cohort study of 417 patients using hypolipidemic drugs (simvastatin, atorvastatin) between
Cunico C   +3 more
doaj   +3 more sources

The association between TyG index and cardiovascular mortality is modified by antidiabetic or lipid-lowering agent: a prospective cohort study [PDF]

open access: yesCardiovascular Diabetology
Background The triglyceride-glucose (TyG) index is recognized as an alternative measure of insulin resistance (IR) and has been linked to the risks of cardiovascular disease (CVD) and mortality.
Changchang Fang   +10 more
doaj   +2 more sources

Synthesis and In Vitro Evaluation of Caffeoylquinic Acid Derivatives as Potential Hypolipidemic Agents [PDF]

open access: yesMolecules, 2019
A series of novel caffeoylquinic acid derivatives of chlorogenic acid have been designed and synthesized. Biological evaluation indicated that several synthesized derivatives exhibited moderate to good lipid-lowering effects on oleic acid-elicited lipid ...
Yu Tian   +7 more
doaj   +2 more sources

Trixis angustifolia DC. as a potential plant for the co-management of diabetes mellitus and tuberculosis. [PDF]

open access: yesPLoS ONE
Diabetes mellitus and tuberculosis represent two concurrent conditions that have posed significant challenges to global public health. A comprehensive investigation into new strategies for co-managing both conditions is essential, given the possible drug
Anuar Salazar-Gómez   +7 more
doaj   +2 more sources

The ansamycins: hypolipidemic agents stimulating cholesterol removal by nonclassical mechanisms.

open access: hybridJournal of Lipid Research, 1994
The ansamycins CGP 43371 and CGS 24565 are derivatives of the antibiotic rifamycin that reduce plasma cholesterol levels in both primate and nonprimate species.
J C Gibson, W H Lee, J R Piccolo
doaj   +2 more sources

Nitrogen Monoxide Releasing Nitric Ester Derivatives of Ibuprofen and Naproxen as COX Inhibitors, Anti-Inflammatory and Hypolipidemic Compounds [PDF]

open access: yesMolecules
Nitric esters are among the compounds that can liberate nitrogen monoxide (NO) in the organism. Due to the vasodilatation caused by nitrogen monoxide, NO-donors have been shown to protect endothelial function, acting as vasodilators, promoting efficient ...
Paraskevi Tziona   +4 more
doaj   +2 more sources

New compounds with a dihydropyridine framework as promising hypolipidemic and hepatoprotective agents

open access: diamondResearch Results in Pharmacology
Introduction: To solve the problem of complex and safe pharmacological correction of metabolic disorders, including hyperlipidemia, hyperglycemia, and liver lesions is currently very important. With this in mind, the new derivatives of cyanothioacetamide
Elena S. Ketova   +3 more
doaj   +2 more sources

Cocos Nucifera Endocarp Extract Exhibits Anti-diabetic and Antilipidemic Activities in Diabetic Rat Model [PDF]

open access: yesInternational Journal of Scientific Research in Dental and Medical Sciences, 2022
Background and aim: The fruits of Cocos nucifera have long been used in traditional medicine as anti-inflammatory, antimicrobial, antiparasitic, anticancer, and cardiotonic.
Farjana Akter   +5 more
doaj   +1 more source

The effect of Elettaria cardamomum (cardamom) on the metabolic syndrome: Narrative review [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2021
Metabolic syndrome (MetS), as a health-threatening factor, consists of various symptoms including insulin resistance, high blood sugar, hypertension, dyslipidemia, inflammation, and abdominal obesity that raise the risk of diabetes mellitus and ...
Roghayeh Yahyazadeh   +4 more
doaj   +1 more source

Persistence and Adherence to Cardiovascular Medicines in Australia

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background The burden of cardiovascular disease is increasing, with many people treated for multiple cardiovascular conditions. We examined persistence and adherence to medicines for cardiovascular disease treatment or prevention in Australia.
Juliana de Oliveira Costa   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy